Market Place
Sourcing Support
All News #Library
Others
Iambic to Participate in April Investor Conferences
02 Apr 2026 //
BUSINESSWIRE
Iambic To Participate In March Investor Conferences
02 Mar 2026 //
BUSINESSWIRE
Iambic Therapeutics To Present At J.P. Morgan Health Conference
16 Dec 2025 //
BUSINESSWIRE
Iambic To Participate In November Investor Conferences
04 Nov 2025 //
BUSINESS WIRE
Iambic Collaborates With Jazz Pharma On Her2+ Breast Cancer Study
21 Oct 2025 //
BUSINESSWIRE
Iambic Therapeutics Appoints Shalini Sharp To Board
01 Oct 2025 //
BUSINESSWIRE
Iambic to Present Preclinical IAM1363 NSCLC Data at WCLC 2025
03 Sep 2025 //
BUSINESSWIRE
Iambic Uses Lambda to Develop Enchant AI for Drug R&D
26 Jun 2025 //
BUSINESSWIRE
Iambic Named to CNBC’s 2025 Disruptor 50 List
10 Jun 2025 //
BUSINESSWIRE
Iambic Completes Dose Escalation in Phase 1/1B Study of IAM1363
04 Jun 2025 //
BUSINESSWIRE
Iambic Therapeutics to Participate in June Investor Conferences
28 May 2025 //
BUSINESSWIRE
Iambic Therapeutics Welcomes Dr. Mary Tagliaferri to Board of Directors
05 Sep 2024 //
BUSINESSWIRE
Iambic Closes $50M Series B To Broaden AI-Discovered Oncology Pipeline
18 Jun 2024 //
BUSINESSWIRE
Iambic Her2 Iam1363 Poster: Clinical Stage At Asco 2024
23 May 2024 //
BUSINESSWIRE
Iambic Selects Lambda For Generative AI Drug Discovery Compute Demands
14 May 2024 //
BUSINESSWIRE
Iambic to Present New Pre-Clinical Data for IAM1363 at the AACR Annual Meeting
28 Mar 2024 //
BUSINESSWIRE
Iambic Announces New Research Published in Nature Machine Intelligence
12 Feb 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.